Development of Consciousness Measure and Monitor Device Based on Electroencephalography
1 other identifier
observational
300
1 country
1
Brief Summary
This study aims to develop a consciousness measuring and monitoring device using a single-channel electroencephalogram (EEG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2020
CompletedFirst Submitted
Initial submission to the registry
June 20, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedApril 20, 2023
April 1, 2023
4.6 years
June 20, 2021
April 19, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Consciousness level using the Glasgow Coma Scale (GCS) scale.
The GCS score ranges from 15 to 3 points, with a higher score indicating an alert consciousness and a lower score indicating decreased consciousness. A binary outcome of GCS\<=8 and GCS\>8 will be used in this study.
At the time of study completion (May 31, 2023, anticipated).
Secondary Outcomes (1)
Consciousness level using the AVPU (Alert; Verbal; Pain; Unresponsive) scale.
At the time of study completion (May 31, 2023, anticipated).
Eligibility Criteria
Adult patients with a decreased level of consciousness who have visited the study hospital EDs and have stayed at the ED for less than 12 hours at the time of enrollment will be included.
You may qualify if:
- Adult ED patients with a decreased level of consciousness (verbal, pain, or unresponsive using the AVPU scale, and a GCS-E score of less than 4) who have stayed at the ED for less than 12 hours at the time of enrollment.
You may not qualify if:
- Patients with the difficulty of applying EEG due to head trauma or skull deformities.
- Patients for whom standard treatment may be significantly delayed by applying the EEG device.
- Patients with a guardian who do not agree to enroll in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Ki Hong Kim
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2021
First Posted
July 7, 2021
Study Start
July 28, 2020
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
April 20, 2023
Record last verified: 2023-04